These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 23124563

  • 1. Synthesis of a key intermediate for the preparation of FTY720 analogs.
    Hamada M, Adachi K, Hikawa H, Yokoyama Y.
    Chem Pharm Bull (Tokyo); 2012; 60(11):1395-8. PubMed ID: 23124563
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs.
    Foss FW, Mathews TP, Kharel Y, Kennedy PC, Snyder AH, Davis MD, Lynch KR, Macdonald TL.
    Bioorg Med Chem; 2009 Aug 15; 17(16):6123-36. PubMed ID: 19632123
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibody against a novel, myriocin (ISP-I)-based immunosuppressant, FTY720.
    Fujita T, Matsumoto N, Uchida S, Kohno T, Shimizu T, Hirose R, Yanada K, Kurio W, Watabe K.
    Bioorg Med Chem Lett; 2000 Feb 21; 10(4):337-9. PubMed ID: 10714494
    [Abstract] [Full Text] [Related]

  • 7. ACS chemical neuroscience molecule spotlight on gilenya (fingolimod; FTY720).
    Hopkins CR.
    ACS Chem Neurosci; 2011 Mar 16; 2(3):116-7. PubMed ID: 22778861
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis of the key intermediate, diethyl 2-acetylamino-2-(2-(4-octanoylphenyl)ethyl)propane-1,3-dioate, of the immunomodulatory agent FTY720 (fingolimod).
    Matsumoto N, Hirose R, Sasaki S, Fujita T.
    Chem Pharm Bull (Tokyo); 2008 Apr 16; 56(4):595-7. PubMed ID: 18379116
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues.
    Högenauer K, Billich A, Pally C, Streiff M, Wagner T, Welzenbach K, Nussbaumer P.
    ChemMedChem; 2008 Jul 16; 3(7):1027-9. PubMed ID: 18383466
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols.
    Kiuchi M, Adachi K, Kohara T, Minoguchi M, Hanano T, Aoki Y, Mishina T, Arita M, Nakao N, Ohtsuki M, Hoshino Y, Teshima K, Chiba K, Sasaki S, Fujita T.
    J Med Chem; 2000 Jul 27; 43(15):2946-61. PubMed ID: 10956203
    [Abstract] [Full Text] [Related]

  • 15. Iron-catalyzed cross-coupling reactions. A scalable synthesis of the immunosuppressive agent FTY720.
    Seidel G, Laurich D, Fürstner A.
    J Org Chem; 2004 May 28; 69(11):3950-2. PubMed ID: 15153030
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and evaluation of fluorinated fingolimod (FTY720) analogues for sphingosine-1-phosphate receptor molecular imaging by positron emission tomography.
    Shaikh RS, Schilson SS, Wagner S, Hermann S, Keul P, Levkau B, Schäfers M, Haufe G.
    J Med Chem; 2015 Apr 23; 58(8):3471-84. PubMed ID: 25826109
    [Abstract] [Full Text] [Related]

  • 18. TX-2152: a conformationally rigid and electron-rich diyne analogue of FTY720 with in vivo antiangiogenic activity.
    Nakayama S, Uto Y, Tanimoto K, Okuno Y, Sasaki Y, Nagasawa H, Nakata E, Arai K, Momose K, Fujita T, Hashimoto T, Okamoto Y, Asakawa Y, Goto S, Hori H.
    Bioorg Med Chem; 2008 Aug 15; 16(16):7705-14. PubMed ID: 18678496
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.